Ken Griffin Treace Medical Concepts, Inc. Transaction History

Citadel Advisors LLC

$509 Billion
Q1 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 17,900 shares of TMCI stock, worth $102,746. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,900

Previous 39,100 54.22%

Holding current value

$102,746

Previous $290,000 48.28%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$7.3 - $10.54 $69,364 - $100,151	9,502 Added 3.63%	271,272 $2.28 Million
Q4 2024 Feb 14, 2025	BUY	$4.66 - $8.78 $891,131 - $1.68 Million	191,230 Added 271.09%	261,770 $1.95 Million
Q3 2024 Nov 14, 2024	SELL	$5.01 - $8.45 $2.11 Million - $3.56 Million	-421,334 Reduced 85.66%	70,540 $409,000
Q2 2024 Aug 14, 2024	BUY	$4.17 - $12.62 $1.78 Million - $5.4 Million	427,755 Added 667.13%	491,874 $3.27 Million
Q1 2024 May 15, 2024	SELL	$11.48 - $15.86 $794,129 - $1.1 Million	-69,175 Reduced 51.9%	64,119 $836,000
Q4 2023 Feb 14, 2024	BUY	$6.03 - $12.88 $44,242 - $94,500	7,337 Added 5.83%	133,294 $1.7 Million
Q3 2023 Nov 14, 2023	BUY	$12.16 - $24.87 $760,863 - $1.56 Million	62,571 Added 98.71%	125,957 $1.65 Million
Q2 2023 Aug 14, 2023	SELL	$23.91 - $27.81 $11.9 Million - $13.9 Million	-498,726 Reduced 88.72%	63,386 $1.62 Million
Q1 2023 May 15, 2023	BUY	$20.23 - $26.22 $4.16 Million - $5.39 Million	205,474 Added 57.61%	562,112 $14.2 Million
Q4 2022 Feb 14, 2023	BUY	$20.54 - $24.67 $4.17 Million - $5.01 Million	203,216 Added 132.46%	356,638 $8.2 Million
Q3 2022 Nov 14, 2022	BUY	$14.71 - $24.18 $1.32 Million - $2.17 Million	89,752 Added 140.96%	153,422 $3.39 Million

Others Institutions Holding TMCI

# of Institutions

142

Shares Held

39M

Call Options Held

39.7K

Put Options Held

View Full List

About TREACE MEDICAL CONCEPTS, INC.

Ticker TMCI
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 55,403,300
Market Cap $318M
Description
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...

More about TMCI

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account